United Kingdom· GB-APID-18770411000001106
Trobalt 200mg tablets
A retigabine product containing retigabine, registered in United Kingdom by GlaxoSmithKline UK Ltd. The same ATC class is registered in 3 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Retigabine is registered in 3 of 19 countries.
Countries holding a registration under ATC N03AX21 (retigabine), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 2 of them publish a price we can compare per daily dose
Retigabine · ATC N03AX21
3 / 19 countries
- Belgiumprice
- Finlandprice
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Retigabine
- Manufacturer
- GlaxoSmithKline UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- N03AX21
- ATC class
- Retigabine
- Defined daily dose
- 0.9 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5000123113804
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
226 interactions on record for retigabine.
Graded by severity as the source publishes them — 40 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Retigabine · interactions on record
226 records
- 40 severe
- 183 moderate
- 3 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- EdoxabanB01AF03severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Retigabine in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aa977682-0662-4f83-85d2-747f92e1cf77 GET /v1/drugs/aa977682-0662-4f83-85d2-747f92e1cf77?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "18770411000001106",
"desc": "Trobalt 200mg tablets (GlaxoSmithKline UK Ltd)",
"form": "Oral tablet",
"vpid": "42136211000001108",
"source": "dmd",
"vtm_id": "777427009",
"strength": "200 mg",
"substance": "Retigabine",
"ingredient": "Retigabine",
"supplier_code": "4012301000001105"
}See everything about retigabine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.